• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Bionano to Report Third Quarter 2024 Financial Results and Host a Conference Call and Webcast on November 13, 2024

    11/7/24 4:01:00 PM ET
    $BNGO
    Biotechnology: Laboratory Analytical Instruments
    Industrials
    Get the next $BNGO alert in real time by email

    SAN DIEGO, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ:BNGO) today announced that it will host a conference call and live webcast on Wednesday, November 13, 2024, at 4:30 p.m. Eastern Time to report financial results for the third quarter 2024 and to highlight recent corporate progress.

    Conference Call & Webcast Details

    Date:Wednesday, November 13th, 2024
    Time:4:30 p.m. ET
    Participant Link:Registration – Click Here
    Webcast Link:https://edge.media-server.com/mmc/p/dmabxin9



    Participants may access a live webcast of the call on the Investors page of the Bionano website. A replay of the conference call and webcast will be archived on Bionano's investor relations website at https://ir.bionano.com/ for at least 30 days.

    CONTACTS

    Company Contact:

    Erik Holmlin, CEO

    Bionano Genomics, Inc.

    +1 (858) 888-7610

    [email protected]

    Investor Relations:

    David Holmes

    Gilmartin Group

    +1 (858) 888-7625

    [email protected]



    Primary Logo

    Get the next $BNGO alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $BNGO

    DatePrice TargetRatingAnalyst
    11/15/2024Buy → Neutral
    Ladenburg Thalmann
    9/10/2024Buy → Neutral
    BTIG Research
    1/5/2023$4.00Sector Outperform
    Scotiabank
    12/12/2022$3.50Buy
    BTIG Research
    7/18/2022$12.00Outperform
    Oppenheimer
    More analyst ratings

    $BNGO
    SEC Filings

    See more
    • Amendment: Bionano Genomics Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

      8-K/A - Bionano Genomics, Inc. (0001411690) (Filer)

      6/18/25 5:15:40 PM ET
      $BNGO
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Bionano Genomics Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders

      8-K - Bionano Genomics, Inc. (0001411690) (Filer)

      6/13/25 4:24:27 PM ET
      $BNGO
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • SEC Form 10-Q filed by Bionano Genomics Inc.

      10-Q - Bionano Genomics, Inc. (0001411690) (Filer)

      5/14/25 4:11:22 PM ET
      $BNGO
      Biotechnology: Laboratory Analytical Instruments
      Industrials